San Francisco, CA, United States of America

Yi-Chi Su

USPTO Granted Patents = 3 


Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 56(Granted Patents)


Company Filing History:


Years Active: 2007-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yi-Chi Su: Innovator in Cancer Treatment

Introduction

Yi-Chi Su is a prominent inventor based in San Francisco, CA, known for his significant contributions to the field of cancer treatment. With a focus on developing innovative therapies, he has been awarded 3 patents that showcase his expertise and dedication to improving patient outcomes.

Latest Patents

Among his latest patents, Yi-Chi Su has developed groundbreaking methods for treating solid tumors. One of his notable inventions is a neutralizing monoclonal antibody to hepatocyte growth factor. This invention includes a pharmaceutical composition that can be administered to patients, offering new hope in cancer therapy. Another patent focuses on monoclonal antibodies to hepatocyte growth factor, further emphasizing his commitment to advancing treatment options for patients suffering from cancer.

Career Highlights

Yi-Chi Su has made significant strides in his career, particularly through his work at Galaxy Biotech, LLC. His innovative research and development efforts have positioned him as a key player in the biotechnology industry, where he continues to push the boundaries of medical science.

Collaborations

His collaboration with Kyung Jin Kim has been instrumental in driving forward the research and development of new therapeutic approaches. Together, they have worked on various projects aimed at enhancing the efficacy of cancer treatments.

Conclusion

Yi-Chi Su's contributions to cancer treatment through his patents and collaborative efforts highlight his role as an influential inventor in the biotechnology field. His work continues to inspire advancements that may lead to better treatment options for patients in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…